Literature DB >> 15254225

Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway.

Hiroko Yaguchi1, Naganari Ohkura, Maho Takahashi, Yuko Nagamura, Issay Kitabayashi, Toshihiko Tsukada.   

Abstract

MEN1 is a tumor suppressor gene that is responsible for multiple endocrine neoplasia type 1 (MEN1) and that encodes a 610-amino-acid protein, called menin. While the majority of germ line mutations identified in MEN1 patients are frameshift and nonsense mutations resulting in truncation of the menin protein, various missense mutations have been identified whose effects on menin activity are unclear. For this study, we analyzed a series of menin proteins with single amino acid alterations and found that all of the MEN1-causing missense mutations tested led to greatly diminished levels of the affected proteins in comparison with wild-type and benign polymorphic menin protein levels. We demonstrate here that the reduced levels of the mutant proteins are due to rapid degradation via the ubiquitin-proteasome pathway. Furthermore, the mutants, but not wild-type menin, interact both with the molecular chaperone Hsp70 and with the Hsp70-associated ubiquitin ligase CHIP, and the overexpression of CHIP promotes the ubiquitination of the menin mutants in vivo. These findings reveal that MEN1-causing missense mutations lead to a loss of function of menin due to enhanced proteolytic degradation, which may be a common mechanism for inactivating tumor suppressor gene products in familial cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254225      PMCID: PMC444842          DOI: 10.1128/MCB.24.15.6569-6580.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  Dynamic changes in the localization of thermally unfolded nuclear proteins associated with chaperone-dependent protection.

Authors:  E A Nollen; F A Salomons; J F Brunsting; J J van der Want; O C Sibon; H H Kampinga
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

2.  Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells.

Authors:  He-Jin Lee; Seung-Jae Lee
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

Review 3.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

Review 4.  The Hsp70 and Hsp60 chaperone machines.

Authors:  B Bukau; A L Horwich
Journal:  Cell       Date:  1998-02-06       Impact factor: 41.582

5.  Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23.

Authors:  N Ohkura; M Kishi; T Tsukada; K Yamaguchi
Journal:  Biochem Biophys Res Commun       Date:  2001-04-20       Impact factor: 3.575

6.  Expression analysis of phenylketonuria mutations. Effect on folding and stability of the phenylalanine hydroxylase protein.

Authors:  A Gámez; B Pérez; M Ugarte; L R Desviat
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

7.  The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation.

Authors:  G C Meacham; C Patterson; W Zhang; J M Younger; D M Cyr
Journal:  Nat Cell Biol       Date:  2001-01       Impact factor: 28.824

8.  The EWS/NOR1 fusion gene product gains a novel activity affecting pre-mRNA splicing.

Authors:  Naganari Ohkura; Hiroko Yaguchi; Toshihiko Tsukada; Ken Yamaguchi
Journal:  J Biol Chem       Date:  2001-10-22       Impact factor: 5.157

9.  Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23.

Authors:  Hiroko Yaguchi; Naganari Ohkura; Toshihiko Tsukada; Ken Yamaguchi
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

10.  Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism.

Authors:  A A J Pannett; A M Kennedy; J J O Turner; S A Forbes; B M Cavaco; J H D Bassett; L Cianferotti; B Harding; B Shine; F Flinter; C G H Maidment; R Trembath; R V Thakker
Journal:  Clin Endocrinol (Oxf)       Date:  2003-05       Impact factor: 3.478

View more
  33 in total

1.  Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).

Authors:  Lucie Canaff; Jean-François Vanbellinghen; Hiroshi Kaji; David Goltzman; Geoffrey N Hendy
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

2.  Crystal structure of menin reveals binding site for mixed lineage leukemia (MLL) protein.

Authors:  Marcelo J Murai; Maksymilian Chruszcz; Gireesh Reddy; Jolanta Grembecka; Tomasz Cierpicki
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

Review 3.  Challenges and opportunities in targeting the menin-MLL interaction.

Authors:  Tomasz Cierpicki; Jolanta Grembecka
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

4.  Interplay between menin and K-Ras in regulating lung adenocarcinoma.

Authors:  Yuan Wu; Zi-Jie Feng; Shu-Bin Gao; Smita Matkar; Bin Xu; Hong-Bin Duan; Xiao Lin; Shan-Hua Li; Xianxin Hua; Guang-Hui Jin
Journal:  J Biol Chem       Date:  2012-10-01       Impact factor: 5.157

Review 5.  Epigenetic regulation by the menin pathway.

Authors:  Zijie Feng; Jian Ma; Xianxin Hua
Journal:  Endocr Relat Cancer       Date:  2017-08-15       Impact factor: 5.678

Review 6.  Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.

Authors:  Koen M A Dreijerink; H T Marc Timmers; Myles Brown
Journal:  Endocr Relat Cancer       Date:  2017-08-15       Impact factor: 5.678

7.  New splicing mutation of MEN1 gene affecting the translocation of menin to the nucleus.

Authors:  H P Tala; C A Carvajal; A A González; J L Garrido; J Tobar; A Solar; C Campino; E Arteaga; C E Fardella
Journal:  J Endocrinol Invest       Date:  2006-11       Impact factor: 4.256

8.  Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma.

Authors:  Z Hamze; C Vercherat; A Bernigaud-Lacheretz; W Bazzi; R Bonnavion; J Lu; A Calender; C Pouponnot; P Bertolino; C Roche; R Stein; J Y Scoazec; C X Zhang; M Cordier-Bussat
Journal:  Endocr Relat Cancer       Date:  2013-10-24       Impact factor: 5.678

9.  Proteasome inhibition rescues clinically significant unstable variants of the mismatch repair protein Msh2.

Authors:  Tim Arlow; Kristan Scott; Aubrey Wagenseller; Alison Gammie
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

10.  SUMO modification of menin.

Authors:  Zi-Jie Feng; Buddha Gurung; Guang-Hui Jin; Xiao-Lu Yang; Xian-Xin Hua
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.